文献速递外周动脉疾病

编辑精选——急性下肢缺血患者接受血管内治疗与开放手术血运重建的临床结局比较:日本大规模分析

Editor's Choice - Comparison of Clinical Outcomes in Patients with Acute Lower Limb Ischaemia Undergoing Endovascular Therapy and Open Surgical Revascularisation: A Large Scale Analysis in Japan.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-08-30

基于日本全国性数据库(2012年4月至2020年3月)的回顾性分析,纳入10977例下肢急性缺血患者,比较血管内治疗(EVT)与开放手术血运重建(OSR)的临床结局。倾向评分匹配后,EVT组院内死亡率、大截肢率、大截肢和/或死亡率和总住院费用均显著高于OSR组。交互分析显示,外周动脉疾病(PAD)是降低OSR在大截肢和/或死亡率方面疗效的因素。

要点

  • 倾向评分匹配后,EVT组院内死亡率(OR 1.33)、大截肢率(OR 1.43)、大截肢和/或死亡率(OR 1.42)均显著高于OSR组。
  • 交互分析显示,PAD是降低OSR在大截肢和/或死亡率方面疗效的因素(有PAD OR 0.94 vs 无PAD OR 1.56;p = .004)。

核心结论

  • 在日本,对于急性下肢缺血患者,EVT作为主要治疗效果不如OSR,但合并PAD的患者除外。

研究设计与样本

  • 回顾性分析,数据来自日本全国心血管疾病登记-诊断程序组合数据库(2012年4月至2020年3月),共分析10977例下肢急性缺血患者。
  • EVT定义为导管定向溶栓、经皮血栓清除术或经皮球囊扩张和/或支架植入的血管成形术。
  • OSR定义为Fogarty血栓切除术、旁路手术或血栓内膜剥脱术。
  • 采用倾向评分匹配(PSM)比较EVT组和OSR组,匹配考虑10个临床协变量。

主要发现

  • EVT组中动脉粥样硬化疾病高风险患者多于OSR组,而OSR组中栓塞高风险患者(包括心房颤动和心房扑动)多于EVT组。
  • EVT组中20.4%的患者接受了使用尿激酶的导管定向溶栓,尿激酶是日本唯一纳入保险的溶栓剂。
  • PSM后,EVT组院内死亡率(OR 1.33,95% CI 1.11 - 1.59;p = .002)、大截肢率(OR 1.43,95% CI 1.19 - 1.72;p < .001)、大截肢和/或死亡率(OR 1.42,95% CI 1.24 - 1.62;p < .001)均显著高于OSR组。
  • 交互分析显示,PAD是降低OSR在大截肢和/或死亡率方面疗效的因素(有PAD OR 0.94,95% CI 0.68 - 1.29;无PAD OR 1.56,95% CI 1.34 - 1.82;p = .004)。

临床怎么用

  • 原文未据此给出推荐,结论为在日本EVT作为急性下肢缺血的主要治疗效果不如OSR,但合并PAD的患者除外。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The recommended revascularisation methods for acute limb ischaemia (ALI), which is caused by embolism and atherosclerotic thrombosis, include endovascular therapy (EVT) and open surgical revascularisation (OSR); however, treatment choices based on patient characteristics remain controversial. This retrospective analysis from the Japanese Registry of All Cardiac and Vascular Diseases - Diagnosis Procedure Combination database (April 2012 to March 2020) evaluated differences in clinical outcomes and identified prognostic predictors in patients with ALI. METHODS: This study analysed 10 977 patients with lower limb ALI. EVT was defined as catheter directed thrombolysis, percutaneous thrombectomy, or percutaneous angioplasty with balloon dilatation and or stenting. OSR was defined as Fogarty thrombectomy, bypass surgery, or thromboendarterectomy. The EVT and OSR groups were compared after propensity score matching (PSM) considering ten clinical covariables. RESULTS: The EVT group had more patients at higher risk of atherosclerotic disease than the OSR group. The OSR group had more patients at a higher risk of embolism, including atrial fibrillation and atrial flutter, than the EVT group. In the EVT group, 20.4% of patients underwent catheter directed thrombolysis using urokinase, the only thrombolytic agent available in Japan that is covered under insurance. After PSM, in hospital mortality (odds ratio [OR] 1.33, 95% confidence interval [CI] 1.11 - 1.59; p = .002), major amputation rate (OR 1.43, 95% CI 1.19 - 1.72; p < .001), major amputation and or death rate (OR 1.42, 95% CI 1.24 - 1.62; p < .001), and total hospitalisation cost (1.16 vs. 0.97 million yen; p < .001) were statistically significantly more common in the EVT group. In interaction analyses, peripheral artery disease (PAD) was a factor responsible for reducing OSR efficacy in terms of major amputation and or death rate (with PAD, OR 0.94, 95% CI 0.68 - 1.29; without PAD, OR 1.56, 95% CI 1.34 - 1.82; p = .004). CONCLUSION: In Japan, EVT was a less effective primary treatment for patients with ALI than OSR, except for those with PAD.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ozawa T, Yanishi K, Fujioka A, et al. Editor's Choice - Comparison of Clinical Outcomes in Patients with Acute Lower Limb Ischaemia Undergoing Endovascular Therapy and Open Surgical Revascularisation: A Large Scale Analysis in Japan. Eur J Vasc Endovasc Surg. 2024. PMID: 39218296. doi:10.1016/j.ejvs.2024.08.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。